HPV types present in invasive cervical cancers of HIV-seropositive women

International Journal of Cancer

Volumn 123, Issue 5, 2008, Pages 1224-1225

  Strickler, Howard D ^a   Palefsky, Joel M ^b   Burk, Robert D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRACE ELEMENT; WART VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER RISK; CARCINOGENESIS; CD4 LYMPHOCYTE COUNT; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 16; HUMAN IMMUNODEFICIENCY VIRUS 18; IMMUNOSUPPRESSIVE TREATMENT; LETTER; PREVALENCE; PRIORITY JOURNAL; SERODIAGNOSIS; UTERINE CERVIX CANCER; WART VIRUS; CANCER INVASION; COMPARATIVE STUDY; EPIDEMIOLOGY; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOLOGY; INTERNATIONAL COOPERATION; ISOLATION AND PURIFICATION; KENYA; NOTE; PATHOLOGY; UNITED STATES; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

CD4 LYMPHOCYTE COUNT; FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMAN PAPILLOMAVIRUS 16; HUMANS; INTERNATIONAL COOPERATION; KENYA; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASM INVASIVENESS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SEROEPIDEMIOLOGIC STUDIES; TUMOR VIRUS INFECTIONS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 47249114445     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23630     Document Type: Letter

References (8)

1. De Vuyst H, Gichangi P, Estambale B, Njuguna E, Franceschi S, Temmerman M. Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya. Int J Cancer 2008;122:244-6.
2. Clifford GM, Goncalves MA, Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. Aids 2006;20:2337-44.
3. Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, Duerr A, Massad LS, Celentano DD, Hall C, Fazzari M, Cu-Uvin S, et al. Human papillomavirus type 16 and immune status in human immunodeficiency virus - seropositive women. J Natl Cancer Inst 2003;95:1062-71.
4. Kamal SM, El Sayed Khalifa K. Immune modulation by helminthic infections: worms and viral infections. Parasite Immunol 2006;28:483-96.
5. Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ. Spectrum of AIDS-associated malignant disorders. Lancet 1998;351:1833-9.
6. Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA. Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 2003;32:527-33.
7. Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA. Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer 2006;118:985-90.
8. Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, Stringer JS, Parham GP. Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer 2007;96:1480-3.